New Products - From Ideas to Markets
Within this course, students can choose to focus on the topic Health Care Technologies. For more information, please refer to the website of the organizing institute: https://www.isto.bwl.uni-muenchen.de/studium_lehre/wise2020-21/master20_21/new_products/index.html
Market access for new drugs in Germany is mainly determined by the early benefit assessment which is set out in the AMNOG law.
2 February 2021, 12:00-14:00 s.t.
Dr. Maximilian Hatz, Senior Market Access Medicines Lead at Astellas Pharma GmbH, will present his guest lecture on „Lessons learned from 10 years with AMNOG”.
Access via Zoom, https://lmu-munich.zoom.us/j/706616165
Meeting Nr. 706616165, Password HEM80539.